PROS1 and posterior cortical atrophy: Until today, the rate of PCa diagnoses has dramatically increased due to the higher life expectancy of today's population as well as prostate specific antigen [PSA; kallikrein-related peptidase 3 (KLK3)] screening resulting in early detection of PCa.